Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

MedWellAI (MWAI) Shares Outstanding (2016 - 2026)

MedWellAI has reported Shares Outstanding over the past 12 years, most recently at $6.2 million for Q4 2025.

  • Quarterly Shares Outstanding rose 554262.67% to $6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2025, up 554262.67% year-over-year, with the annual reading at $6.2 million for FY2025, 1137.32% up from the prior year.
  • Shares Outstanding was $6.2 million for Q4 2025 at MedWellAI, up from $500000.0 in the prior quarter.
  • Over five years, Shares Outstanding peaked at $205.1 million in Q1 2022 and troughed at $1125.0 in Q4 2024.
  • The 5-year median for Shares Outstanding is $2.2 million (2022), against an average of $12.8 million.
  • Year-over-year, Shares Outstanding tumbled 100.0% in 2021 and then surged 554262.67% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $1125.0 in 2021, then skyrocketed by 72134.04% to $812633.0 in 2022, then crashed by 99.63% to $3000.0 in 2023, then plummeted by 62.5% to $1125.0 in 2024, then surged by 554262.67% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Shares Outstanding are $6.2 million (Q4 2025), $6.2 million (Q3 2025), and $6.2 million (Q2 2025).